Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Dose-Response of Adenosine for Perioperative Pain

ClinicalTrials.gov ID: NCT00298636

Public ClinicalTrials.gov record NCT00298636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Escalating Dose-Response Trial of Intravenous Adenosine for Perioperative Analgesia in Females Undergoing Abdominal Hysterectomy or Myomectomy

Study identification

NCT ID
NCT00298636
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Xsira Pharmaceuticals
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • adenosine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2005
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 1, 2006

Started 2005

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
University of California, San Francisco San Francisco California 94143
University of Miami/Miller School of Medicine Miami Florida 33136
Medical College of Georgia Augusta Georgia 30912
University of Chicago Chicago Illinois 60637
Duke University Medical Center Durham North Carolina 27710
Wake Forest University/Forsyth Medical Center Winston-Salem North Carolina 27157
Thomas Jefferson University Philadelphia Pennsylvania 19107
Memorial Hermann-Memorial City Hospital Houston Texas 77024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00298636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 1, 2006 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00298636 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →